Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Nerlynx {black_triangle}

Active Ingredient:
neratinib maleate
Company:  
Pierre Fabre Limited See contact details
ATC code: 
L01EH02
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Nerlynx (neratinib) Patient Alert Card

This card is for patients who are prescribed Neratinib, to carry with them and provide to a non-routine treating clinician to inform them of key information about their neratinib treatment

{pdf_link}

Nerlynx Patient Treatment Journal

This document forms one part of the Physician/HCP and Patient/Carer Educational Materials for Nerlynx (neratinib). It is provided for patients to complete on a daily basis to assist with the management of any diarrhoea patients may experience.

{pdf_link}

Nerlynx Risk Minimisation Guide for Healthcare Professionals on diarrhoea management

{healthcare_pro_orange} For Healthcare Professionals

This Risk Minimisation Guide is one part of the Physician/HCP Educational Materials. The aim of this brochure is to provide HCPs with information on the management of diarrhoea when prescribing Nerlynx (neratinib).

{pdf_link}

Nerlynx Risk Minimisation Materials - Patient/Carer guide how to manage diarrhoea with Nerlynx

This Risk Minimisation Guide is one part of the Physician/HCP and Patient/Carer Educational Materials for Nerlynx. This brochure provides specific guidance to patients on how to recognise and manage diarrhoea if it occurs whilst taking Nerlynx (neratinib).

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Pierre Fabre Limited
Company image
Address
250 Longwater Avenue, Green Park, Reading, RG2 6GP, UK
Telephone
0118 334 8003
Medical Information Direct Line
0800 085 5292
Medical Information e-mail
[email protected]